Figure 1.
The oral administration of Ga reduces hepatic TG content and hyperglycemia in a dose-dependent manner. BW gain from the initiation day of Ga administration (1-1) and cumulative food intake (1-2) were measured daily (n = 7 in each group). After 14 days of treatment, hepatic TG content (1-3), insulin resistance (1-4), blood levels of glucose (1-5), insulin (1-6) and leptin (1-7), and HOMAβ values (1-8) were determined. Saline, G-Low, G-Med and G-High represent the saline-treated, low Ga dose-treated, medium Ga dose-treated and high Ga dose-treated groups, respectively. Data are presented as the mean ± SEM. *P < 0.05 and **P < 0.01 compared to the saline-treated group, respectively.